Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence04:54

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence

587
In this video, we demonstrate a method to evaluate the effect of osmolytes on the formation of bacterial persisters. The bacterial cells are first exposed to osmolytes to induce osmotic stress, triggering persister formation, then treated with antibiotics to enumerate the...
587
Ethical Issues01:27

Ethical Issues

2.0K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.0K
The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time06:05

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

1.6K
This protocol describes a novel method for collecting and analyzing data related to ongoing implementation called the Participant-Reported Implementation Update and Score (PRIUS). The PRIUS method allows for the efficient and systematic capture of data over time and from multiple viewpoints in healthcare settings.
1.6K
The Costs of Issuing Securities01:30

The Costs of Issuing Securities

211
Issuing securities entails various costs, collectively referred to as issuance costs, which reduce the net proceeds a company receives. These costs depend on factors such as the type of security, issuance size, and prevailing market conditions.Key issuance costs include underwriting, legal, accounting, and registration fees. Underwriting fees compensate financial institutions that facilitate the sale of securities. Legal fees cover regulatory compliance, while accounting fees ensure...
211
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

13.2K
The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
13.2K
Nursing Implementation01:15

Nursing Implementation

6.0K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.

Topics in antiviral medicine·2026
Same author

Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

"It's like scratching at the door": Experiences of outpatient buprenorphine low dose initiation among people using fentanyl.

Journal of substance use and addiction treatment·2026
Same author

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV.

Addiction science & clinical practice·2025
Same author

The Urgency of Now: Congenital Syphilis in the Doxycycline Post-exposure Prophylaxis Era.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?

The Journal of infectious diseases·2025
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence
04:54

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence

587

Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation

Matthew A Spinelli1,2, Susan P Buchbinder1,2,3

  • 1Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|September 12, 2019
PubMed
Summary

No abstract available in PubMed .

Keywords:
HIVMSMPrEPPre-exposure prophylaxispersistence

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
The Costs of Issuing Securities
01:30

The Costs of Issuing Securities

Published on: April 11, 2025

211

Related Experiment Videos

Last Updated: Jan 19, 2026

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence
04:54

In Vitro Persister Assay: A Method to Evaluate the Effect of Osmolytes on Bacterial Persistence

587
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
The Costs of Issuing Securities
01:30

The Costs of Issuing Securities

Published on: April 11, 2025

211